ReCerf Hip Resurfacing Clinical Investigation

MatOrtho Limited0 个研究点目标入组 78 人开始时间: 2020年10月15日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•1. Patient suitable for hip resurfacing arthroplasty
•2. Patient able to give informed consent
•3. Patient willing and able to take part in the study for the prescribed length of the study
•4. Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study
•5. Minimum age of 18 years

•1. Patient deemed unsuitable for hip resurfacing arthroplasty by the surgeon
•2. Patient has significant contraindications when following the manufacturer's Instruction For Use of the product
•3. Patient likely to become incapacitated during the study
•4. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study

发起方